HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People On The Move: Appointments At Stada, GSK And Pfizer

Executive Summary

Stada poaches CHC industry veterans from RB and Teva, GSK promotes a new head of CHC in Romania and the Balkans and Pfizer names DACH managing director.

You may also be interested in...



Stada Reveals Skin-Care Ambitions With Acquisition Of GSK Brands

Stada has snapped up a basket of OTC skin-care brands from GSK, with CEO Peter Goldschmidt telling HBW Insight that the category is a "key focus" for the Germany-based firm.

Pfizer Feels The Heat As ThermaCare Recall Spreads To Europe

A problem with overheating heat cells in Pfizer's ThermaCare OTC pain-relief patch is not limited to the US market, the company has discovered, prompting recalls across four European markets.

Don’t Be Afraid To Try Something New – Q&A With GSK Marketing Exec Stephen Glynn

GSK Consumer Healthcare's engagement director Stephen Glynn gives his insight into how digital is shaking up OTC drug marketing and talks about the experiences that have shaped his career.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS148948

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel